FNY Investment Advisers’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-130	Closed	-$1K	–	713
2021 Q2	$1K	Buy	+130	New	+$1K	﹤0.01%	648